Synthesis and biological activity of alpha-L-fucosyl ceramides, analogues of the potent agonist, alpha-D-galactosyl ceramide KRN7000.
Several L-fucoglycolipids are associated with diseases such as cancer, cystic fibrosis and rheumatoid arthritis. Activation of iNKT cells is known to lead to the production of cytokines that can help alleviate or exacerbate these conditions. alpha-Galactosyl ceramide (alpha-GalCer) is a known agonist of iNKT cells and it is believed that its fucosyl counterpart might have similar immunogenic properties. We herein report the synthesis of alpha-L-fucosyl ceramide derivatives and describe their biological evaluation. The key challenge in the synthesis of the target molecules involved the stereoselective synthesis of the alpha-glycosidic linkage. Of the methods examined, the per-TMS-protected glycosyl iodide donor was completely alpha-selective, and could be scaled up to provide gram quantities of the azide precursor 11, from which a range of N-acylated alpha-L-fucosyl ceramides were readily obtained and evaluated for ex vivo expansion of human iNKT cells.
Veerapen
Natacha
N
School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
Reddington
Faye
F
Bricard
Gabriel
G
Porcelli
Steven A
SA
Besra
Gurdyal S
GS
D000215:Acylation; D002518:Ceramides / Q000138:chemical synthesis* / Q000494:pharmacology*; D005699:Galactosylceramides / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D009000:Monocytes / Q000187:drug effects
D002518:Ceramides; D005699:Galactosylceramides; C103873:KRN 7000
Carbohydr Res. 2002 Nov 19;337(21-23):1953-65
12433461
Nature. 2007 Jul 5;448(7149):44-9
17581592
Carbohydr Res. 2009 Jun 12;344(9):1110-22
19410241
Cancer Res. 1983 Nov;43(11):5489-92
6193872
Bioorg Med Chem Lett. 2009 Aug 1;19(15):4288-91
19502056
J Biol Chem. 1984 Apr 10;259(7):4672-80
6707026
J Am Chem Soc. 2004 Oct 27;126(42):13602-3
15493902
Biochemistry. 1982 Mar 2;21(5):928-34
7074061
Chem Commun (Camb). 2007 Jun 21;(23):2336-8
17844738
Chem Biol. 2005 Jun;12(6):677-83
15975513
Cancer Res. 1986 May;46(5):2619-26
3008996
Annu Rev Immunol. 2003;21:483-513
12543936
J Org Chem. 2006 Jan 20;71(2):836-9
16409007
Nat Immunol. 2005 Aug;6(8):819-26
16007090
Org Lett. 2001 Jun 28;3(13):2081-4
11418054
Adv Carbohydr Chem Biochem. 1981;39:279-345
7025594
Adv Cancer Res. 1989;52:257-331
2662714
Cancer Res. 1990 Mar 1;50(5):1375-80
2302702
Nat Immunol. 2005 Aug;6(8):810-8
16007091
Cancer Res. 1987 Apr 1;47(7):1968-72
3815386
Arthritis Rheum. 2004 Jan;50(1):305-13
14730629
Eur J Immunol. 1999 Jun;29(6):2014-25
10382765
Nat Rev Immunol. 2004 Mar;4(3):231-7
15039760
Nature. 2001 Oct 4;413(6855):531-4
11586362
J Immunol. 1999 Nov 1;163(9):4647-50
10528160
J Immunol. 2003 Oct 15;171(8):4020-7
14530322
J Biol Chem. 1976 Apr 25;251(8):2385-7
1262328
Bioorg Med Chem. 1996 Nov;4(11):1833-47
9007268
Biol Pharm Bull. 1995 Nov;18(11):1487-91
8593464
J Exp Med. 2002 Mar 4;195(5):617-24
11877484
Science. 1997 Nov 28;278(5343):1626-9
9374463
Proc Natl Acad Sci U S A. 2005 Mar 1;102(9):3383-8
15722411
Biochim Biophys Acta. 1981 Dec 23;666(3):361-9
6798995